Implement enhanced artificial “intestinal enteroendocrine L cells” via oral administration for effective treatment of type 2 diabetes
收藏国家人口健康科学数据中心2026-06-01 收录
下载链接：
https://www.ncmi.cn/phda/dataDetails.do?id=CSTR:17970.11.A001G.202408.88.V1.0
下载链接
链接失效反馈官方服务：
资源简介：
Intestinal enteroendocrine L cells, responsive for secreting glucagon-like peptide-1 (GLP-1) to normalize blood glucose level, are negatively affected when type 2 diabetes (T2D) develops. Here, we designed enhanced artificial “intestinal enteroendocrine L cells” (EcN-GLP-1@Fe-TA-Pe@CLGN) for T2D treatment via oral administration.
提供机构：
北京蛋白质组研究中心
创建时间：
2024-08-09
